Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/12938
Title: Hepatocyte growth factor-induced amelioration in renal interstitial fibrosis is associated with reduced expression of <img src='/image/spc_char/alpha.gif' border=0>-smooth muscle actin and transforming growth factor-<img src='/image/spc_char/beta.gif' border=0>1
Authors: Wang, Hong-yue
Wang, Yan-jun
Cui, Ming-ji
Gu, Chun-mei
Yang, Li-zhi
Zhao, Ying
Chen, Yan
Zhao, Dan
Li, Tian-shu
Chi, Bao-rong
Keywords: PCI-neo-hepatocyte growth factor
5/6 Nephrectomized rats
Transforming growth factor-<img src='/image/spc_char/beta.gif' border=0>1
<img src='/image/spc_char/alpha.gif' border=0>-Smooth muscle actin
Issue Date: Oct-2011
Publisher: NISCAIR-CSIR, India
Abstract: Several studies have shown that hepatocyte growth factor (HGF) ameliorates renal interstitial fibrosis, but the mechanism is not fully clear. This study was designed to examine whether HGF can relieve renal interstitial injury in 5/6 nephrectomized rats, and to confirm whether this function was associated with decrease in <img src='/image/spc_char/alpha.gif' border=0>-smooth muscle actin (<img src='/image/spc_char/alpha.gif' border=0>-SMA) and transforming growth factor-beta1 (TGF-<img src='/image/spc_char/beta.gif' border=0>1) expression. The animals were randomized into 8 groups comprising 6 animals (n = 6) each: control (group I), PCI-neo (group II, 900 μg), sham-operation (group III,not nephrectomy), model or 5/6 nephrectomy group (group IV), lotensin group (an angiotensin converting enzyme inhibitor, group V, 0.6 mg/100 g/day for 5 weeks), low-dose PCI-neo-HGF group (group VI, 690 μg), high-dose PCI-neo-HGF group (group VII, 1380 μg) and lotensin + high-dose PCI-neo-HGF group (group VIII, 0.6 mg/100 g/day for 5 weeks, 1380 μg). The animals were sacrificed in the 5<sup>th</sup> week after 5/6 nephrectomy. The specimens of kidneys were used for pathological examination (hematoxylin-eosin staining), detection of <img src='/image/spc_char/alpha.gif' border=0>-SMA and TGF-<img src='/image/spc_char/beta.gif' border=0>1 mRNA (Reverse transcriptase-polymerase chain reaction) and protein (Western blot and immunohistochemistry) expression. The results showed that in 5/6 nephrectomized rats blood urea nitrogen (BUN), serum creatinine (CRE) and 24 h urinary albumin excretion (UAE) were increased, renal interstitium was injured seriously and <img src='/image/spc_char/alpha.gif' border=0>-SMA, TGF-<img src='/image/spc_char/beta.gif' border=0>1 mRNA and protein expression were elevated compared with those of control. The above changes were ameliorated and <img src='/image/spc_char/alpha.gif' border=0>-SMA and TGF-<img src='/image/spc_char/beta.gif' border=0>1 expression was reduced by both PCI-neo-HGF and lotensin. The lotensin + high-dose PCI-neo-HGF group rats exhibited the most significant therapeutic effect both in decreasing the BUN, CRE and 24 h UAE and in relieving renal interstitial injury. In conclusion, the study demonstrated that HGF can relieve renal interstitial injury and this protection was associated with down-regulation of <img src='/image/spc_char/alpha.gif' border=0>–SMA and TGF-<img src='/image/spc_char/beta.gif' border=0>1 expressions.
Description: 308-315
URI: http://hdl.handle.net/123456789/12938
ISSN: 0975-0959 (Online); 0301-1208 (Print)
Appears in Collections:IJBB Vol.48(5) [October 2011]

Files in This Item:
File Description SizeFormat 
IJBB 48(5) 308-315.pdf412.05 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.